Fig. 2From: The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patientsChanges in laboratory data before and after TXA initiation. Median laboratory data from day 2 to day 30 was analyzed as data after TXA initiation. DIC score was assessed using JMHW diagnostic criteria. TXA: tranexamic acid; DIC: disseminated intravascular coagulation; JMWH: Japanese Ministry of Health and Welfare; PT: prothrombin time; APTT: activated partial thromboplastin time; FDP: fibrin degradation product; PIC: plasmin-α2 plasmin inhibitor complex; TAT: thrombin-antithrombin complexBack to article page